Does the Cytochrome C-Caspase Pathway of Cell Death Occur Physiologically in Animals?
Lucas Zellmer1, Yaping Han1, Lichan Chen1, Ningzhi Xu2* and Dezhong Joshua Liao1,3*
1Hormel Institute, University of Minnesota, USA
2National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
3Animal Facilities, Shandong Academy of Pharmaceutical Sciences, China
Submission: April 09, 2017; Published: May 10, 2017
*Corresponding author: Ningzhi Xu, Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China, Email: [email protected]
Ganesh Chandra Jagetia, Department of Zoology, Mizoram University, Aizwal-796 004, India, Tel: 91-389-2330724/2330227; Email: [email protected]
How to cite this article: Lucas Z, Yaping H, Lichan C, Ningzhi X, Dezhong J L. Does the Cytochrome C-Caspase Pathway of Cell Death Occur Physiologically in Animals?. J Tumor Med Prev. 2017; 1(2): 555557. DOI: 10.19080/JTMP.2017.01.555557
Introduction
There have been numerous published studies on the mechanisms of cell death, so far having established tens of different modes of cell death in the literature. A small number of these reported cell death modes are listed here as examples: necrosis, apoptosis, aponecrosis [1], netosis [2], necroptosis [2,3], parthanatos [4], entosis [5,6], methuosis [7], oncosis [8], paraptosis [9], anoikis [10], pyroptosis [11], ferroptosis [12], phagoptosis [13], caspase-independent apoptosis [14,15], cell death independent of caspases [16], and excite toxicity [17,18]. Some of these reported cell death modes manifest features of programming, usually coined as "programmed cell death”, whereas others do not. Of these modes, apoptosis is the one best- studied of the programmed cell death type, and is considered to use a cascade of cytochrome c (CYTc) and caspases as the overarching pathway or mechanism.
Actually, some other modes of cell death that are considered to be non-apoptosis or not typical apoptosis but show features of programming involve CYTc and caspases as well. Although these CYTc-caspase-involved death modes may have certain differences from one another, in general they are triggered by a form of stress that induces mitochondrial outer membrane permeabilization (MOMP). MOMP leads to loss of mitochondrial functions, including the loss of inner trans membrane potential, which in turn results in release of inter membrane proteins CYTc and Apaf-1 into the cytoplasm, wherein the CYTc and Apaf-1 form a complex to activate initiator caspases, such as caspase 9.Once activated, initiator caspases will cleave (activate) effect or caspases, such as caspases 3 and 7, leading to death of the cell [19-21].
The above-described features of the CYTc-caspase cascade indicate that CYTc has dual functions [21]: at its normal, i.e. physiological, sub cellular location, CYTc participates in ATP production to power the cell, thus resembling an on co protein that sustains the cell's life. However, when it relocates from its normal sub cellular habitat to an abnormal one, i.e. to a pathological sub cellular location, it binds to some death-causing proteins to initiate death of the cell, thus functioning as a tumor suppressor protein. Therefore, the CYTc-caspase-involved cell death is a purely pathological procedure with increased permeability of the mitochondrial membrane and other sub cellular pathological alterations as its early events. Besides CYTc, our cells actually have many other proteins that have similar dual functions and are thus compartmented in (or confined to) a type of organelle as well. Good examples include lysosomal enzymes, which will digest the cell and kill it once being leaked from the lysosome to the cytoplasm. In fact, most genes and their protein products in human cells have dual or multiple functions, with some functions different from or even opposite to the others, which may be one of the reasons why the human genome encodes only slightly over 20,000 protein-coding genes [22-25] but controls the greatly diversified traits of human beings, as we have delineated before [26-28].
For different genes, their functional variation may be regulated at different levels and by different mechanisms, including single nucleotide polymorphism or point mutation of the DNA, variation of the RNA sequence due to alternative initiation or termination of transcription or due to alternative splicing, variation at post- translational modification such as phosphorylation at different sites of a protein, variation at different sub cellular locations of RNAs or proteins, etc [26,28]. For example, the longer RNA splice form of the Bcl-x gene, i.e. Bcl-xL, encodes an on co protein, whereas the shorter RNA splice form of this gene, i.e. Bcl-xS, encodes a tumor suppressor protein. The wild type form of the P53 protein functions mainly as a tumor suppressor but some of the P53 mutants may be oncogenic [27,29]. However, different functions of different P53 proteins are not mainly determined by their sub cellular habitats; whereas CYTc, lysosomal enzymes, and other compartmented proteins manifest different functions when they appear at different sub cellular locations, with one sub cellular habitat being physiological while another being pathological.
Although apoptosis is generally accepted by the cell death research fraternity to be "a mechanism of programmed cell death”, in the literature many different modes of cell death with innate programming features are actually described as "apoptosis” or "apoptotic death”. For instance, on the one hand, those cell deaths of the involution type, such as those during digit individualization in the human embryo, postpartum involution of the uterus, post-lactating (post-weaning) involution of mammary glands, post-pubertal involution of the thymus, etc, are programmed cell deaths occurring in a physiological situation and are described by us as authentic apoptosis [30-32]. On the other hand, in cancer research, almost all cell deaths caused by irradiation, chemo drugs or chemo preventive agents, either in culture dishes or in animals, are described as "apoptosis” as well, albeit all these forms of radiation as well as these chemo drugs or chemo preventive agents are quite different forms of stress to the cells and have quite different physical or chemical properties. It seems that "apoptosis” or "apoptotic death” is quite convenient, at least for cancer researchers, to use without any worry of being questioned. This reality in the literature of cell death research, which is that many different types of cell death in vitro and in vivo are all put under the umbrella of "apoptosis”, clearly indicates that either 1) "apoptosis” has not yet obtained a pellucid definition that is accepted by most peers, or 2) "apoptosis” does have a strict definition but most peers do not follow it, or 3) "apoptosis” has a very broad definition that covers many different modes of cell death with some traits of programming. In our opinion, many, probably most, cancer researchers love the word "apoptosis” and use it at their convenience to describe the cell deaths in their systems that involve CYTc and caspases, such as the deaths caused by their chemo drugs. In other words, the relationship between apoptosis and CYTc-caspases has been upended: Initially, peers studied the mechanism of apoptosis and identified the CYTc-caspase cascade as its overarching pathway, but then peers use the involvement of CYTc-caspases as the criterion to define apoptosis, meaning that it is apoptosis as long as CYTc-caspases are involved.
Cell deaths involving the CYTc-caspase pathway have two common features:
a) It is usually, if not absolutely, triggered by a form of stress to the cell, such as a chemo drug.
b) It requires MOMP that leads to the leak of CYTc from the mitochondrion to the cytoplasm to activate caspases.
These two features clearly indicate that cell death via this path way is a purely pathological event. Ifthis pathological procedure is defined as apoptosis, as it has actually been in numerous studies, a question is thus raised as to whether apoptosis can really occur in animals in a physiological situation. As a more specific example, there is a question of whether the cell deaths during the aforementioned involutions in animals should still be considered as apoptosis, since the death procedure is pre-programmed and is purely physiological in the host animals. A fact that needs to be realized is that, apoptosis initially evolves as a programmed procedure for animals to purge away those cells that are no longer useful for them, in a way without being detrimental to the bodies of the host animals, i.e. in a physiological manner [30-32], whereas most data that establish the CYTc-caspase pathway as an overarching mechanism of apoptosis are derived from studies with pathological systems that involve a sort of stress. Few data are derived from studies on the aforementioned involution type of cell death in animals without an exogenous stress involved. In other words, we need to have more studies on cell deaths with those animal models of involution to determine whether CYTc can still initiate cell death
A. When there is no stress involved, such as no irradiation.
B. When the permeability of the mitochondrial membrane remains normal, or
C. When CYTc still remains at its normal location in mitochondrion without being leaked out to the cytoplasm.
There is some evidence that caspases may not be involved in the massive cell death during post-weaning involution of mouse mammary glands [33], although in our opinion caspases and probably also lysosomal enzymes of macrophages or whatever cells that engulf the dying or dead cells may still be involved to dispose of the cell corpses [32,34]. Therefore, we surmise that the CYTc-caspase cascade may not really be involved in authentic apoptosis occurring in such situations that are physiological to the host animals, exemplified by the aforementioned involution type of cell death [32]. If we agree that apoptosis is initially developed during evolution of the animal kingdom as a physiological mechanism to eliminate obsolete cells, such as those no-longer useful mammary epithelial cells after weaning, we need to reconsider whether cell deaths in pathological situations, mainly those elicited by the CYTc-caspase cascade, should be defined as apoptosis. In our opinion, "apoptosis” should be used to define those cell deaths occurring physiologically in animals without involving any exogenous form of stress, with the abovementioned involution type of cell death as good examples, whereas any of those cell deaths involving a sort of stress should be redefined as "stress-induced cell death”, or SICD, but not as apoptosis [30-32]. Most, if not all, forms of SICD utilize the CYTc-caspase cascade as the overarching mechanism, with cells killed by chemotherapy or radiotherapy as good examples, as has been shown by numerous published studies. The physiological apoptosis and the pathological SICD are irreconcilable to each other, albeit both of them are programmed events and share many similarities, as we have expounded before [31].
Acknowledgement
We would like to thank Dr. Fred Bogott at the Austin Medical Center, Austin of Minnesota, for his excellent English editing of this manuscript. D. Joshua Liao was supported by a grant from Chinese National Science Foundation (grant No. 81660501).
References
- Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, et al. (2000) morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 182(1): 41-49.
- Desai J, Mulay SR, Nakazawa D, Anders HJ (2016) Matters of life and death. How neutrophils die or survive along NET release and is "NETosis”=necroptosis? Cell Mol Life Sci 73(11-12): 2211-2219.
- Hanson B (2016) Necroptosis: A New Way of Dying? Cancer Biol Ther 17(9): 899-910.
- Fatokun AA, Dawson VL, Dawson TM (2014) Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br J Pharmacol 171(8): 2000-2016.
- Florey O, Kim SE, Overholtzer M (2015) Entosis: cell-in-cell formation that kills through entotic cell death. Curr Mol Med 15(9): 861-866.
- Krishna S, Overholtzer M (2016) Mechanisms and consequences of entosis. Cell Mol Life Sci 73(11-12): 2379-2386.
- Maltese WA, Overmeyer JH (2014) Methuosis: non apoptotic cell death associated with vacuolization of macropinosome and endosome compartments. Am J Pathol 184(6): 1630-1642.
- Weerasinghe P, Buja LM (2012) Oncosis: an important non-apoptotic mode of cell death. Exp Mol Pathol 93(3): 302-308.
- Lee D, Kim IY, Saha S, Choi KS (2016) Paraptosis in the anti-cancer arsenal of natural products. Pharmacol Ther 162: 120-133.
- Taddei ML, Giannoni E, Fiaschi T, Chiarugi P (2012) Anoikis: an emerging hallmark in health and diseases. J Pathol 226(2): 380-393.
- Kepp O, Galluzzi L, Zitvogel L, Kroemer G (2010) Pyroptosis - a cell death modality of its kind? Eur J Immunol 40(3): 627-630.
- Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73(11-12): 2195-2209.
- Brown GC, Vilalta A, Fricker M (2015) Phagoptosis - Cell Death By Phagocytosis - Plays Central Roles in Physiology, Host Defense and Pathology. Curr Mol Med 15(9): 842-851.
- Constantinou C, Papas KA, Constantinou AI (2009) Caspase- independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? Curr Cancer Drug Targets 9(6): 717728.
- Tait SW, Green DR (2008) Caspase-independent cell death: leaving the set without the final cut. Oncogene 27(50): 6452-6461.
- Broker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11(9): 3155-3162.
- Jia M, Njapo SA, Rastogi V, Hedna VS (2015) Taming glutamate excite toxicity: strategic pathway modulation for neuroprotection. CNS Drugs 29(2): 153-162.
- Salinska E, Danysz W, Lazarewicz JW (2005) The role of excite toxicity in neuro degeneration. Folia Neuropathol 43(4): 322-339.
- Xiong S, Mu T, Wang G, Jiang X (2014) Mitochondria-mediated apoptosis in mammals. Protein Cell 5(10): 737-749.
- Cosentino K, Garcia-Saez AJ (2014) Mitochondrial alterations in apoptosis. Chem Phys Lipids 181: 62-75.
- Huttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, et al. (2011) The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion 11(3): 369-381.
- Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, et al. (2011) Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 12: 745-55.
- Belizario JE (2013) The humankind genome: from genetic diversity to the origin of human diseases. Genome 56(12): 705-716.
- Pennisi E (2012) Genomics. ENCODE project writes eulogy for junk DNA. Science 337(6099): 1159- 1161.
- Skipper M, Dhand R, Campbell P (2012) Presenting ENCODE. Nature 489(7414): 45.
- Jia Y, Chen L, Ma Y, Zhang J, Xu N, et al. ( 2015) To Know How a Gene Works, We Need to Redefine It First but then, More Importantly, to Let the Cell Itself Decide How to Transcribe and Process Its RNAs. Int J Biol Sci 11(12): 1413-1423.
- Lou X, Zhang J, Liu S, Xu N, Liao DJ (2014) The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis. Cell Cycle 13(11): 1677-1693.
- Liu X, Wang Y, Yang W, Guan Z, Yu W, et al. (2016) Protein multiplicity can lead to misconduct in western blotting and misinterpretation of immunohistochemical staining results, creating much conflicting data. Prog Histochem Cytochem 51(3-4): 51-58.
- Yuan C, Xu N, Liao J (2012) Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing. Cell Cycle 11(18): 3355-3356.
- Liao DJ (2005) The scavenger cell hypothesis of apoptosis: apoptosis redefined as a process by which a cell in living tissue is destroyed by phagocytosis. Med Hypotheses 65(1): 23-28.
- Zhang J, Lou XM, Jin LY, Zhou RJ, Liu SQ, et al. (2014) Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions. Oncoscience 1(6): 407-422.
- Liu B, Xu N, Man Y, Shen H, Avital I, et al. (2013) Apoptosis in Living Animals Is Assisted by Scavenger Cells and Thus May Not Mainly Go through the Cytochrome C-Caspase Pathway. J Cancer 4(9): 716-723.
- Kreuzaler PA, Staniszewska AD, Li W, Omidvar N, Kedjouar B, et al. (2011) Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 13(3): 303-309.
- Liao DJ, Dickson RB (2003) Cell death in MMTV-c-myc transgenic mouse mammary tumors may not be typical apoptosis. Lab Invest 83(10): 1437-1449.